495 Participants Needed

PAP Treatment and Sleep Education for Sleep Apnea

(RESTORE Trial)

MS
JL
NH
Overseen ByNishtha H Pandya
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

Trial Summary

Will I have to stop taking my current medications?

The trial information does not specify if you need to stop taking your current medications. However, if you are using sedative-hypnotic medications above the recommended dose, you may not be eligible to participate.

What data supports the effectiveness of PAP Treatment and Sleep Education for Sleep Apnea?

Research shows that therapeutic patient education, which is part of the sleep education component, has been effective in improving quality of life and treatment adherence in conditions like asthma and atopic dermatitis. This suggests that similar educational approaches could help patients with sleep apnea better manage their condition.12345

Is PAP Treatment and Sleep Education safe for humans?

The research articles provided do not contain specific safety data for PAP Treatment or Sleep Education. However, these treatments are generally considered safe for humans when used as directed by healthcare professionals.26789

How is PAP Treatment and Sleep Education for Sleep Apnea different from other treatments?

This treatment is unique because it combines Continuous Positive Airway Pressure (CPAP) therapy, which uses a machine to help keep airways open during sleep, with a comprehensive sleep education program. The education component empowers patients to understand and manage their condition better, potentially improving adherence to CPAP therapy and overall quality of life.710111213

What is the purpose of this trial?

The purpose of this study is to look at how sleep disordered breathing (SDB) and not getting enough sleep each night contribute to daytime sleepiness. The investigators also want to determine the treatment that works best for improving daytime sleepiness.In this study, the investigators are comparing 2 programs that may improve symptoms of daytime sleepiness.

Research Team

MS

M. Safwan Badr, MD, MBA

Principal Investigator

Wayne State University

Eligibility Criteria

This trial is for adults over 18 with mild to moderate sleep disordered breathing (SDB) and who often get less than 7 hours of sleep. They should feel sleepy during the day, but not be at high risk for falling asleep in dangerous situations like driving. People using certain sleep medications or treatments, those with severe health issues, substance use disorders, or other major sleep conditions can't join.

Inclusion Criteria

You usually sleep less than 7 hours for at least 4 nights every week, as recorded in your sleep diary.
I have been diagnosed with a mild to moderate sleep breathing issue.
I am over 18 years old.
See 1 more

Exclusion Criteria

I am a commercial driver or at high risk for car accidents.
I do not have severe lung or heart disease.
I am currently using a device at night to help with my sleep breathing problem.
See 6 more

Timeline

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks
1 visit (virtual or in-person)

Treatment

Participants receive education about SDB and sleep, with one group receiving PAP devices, over four weekly sessions

4 weeks
4 visits (in-person)

Follow-up

Participants are monitored for safety and effectiveness after treatment, with assessments conducted immediately following the intervention and after 3 months

3 months
2 visits (in-person)

Treatment Details

Interventions

  • PAP Treatment
  • Sleep Education I
  • Sleep Education II
Trial Overview The study aims to see which of two programs—PAP Treatment or Sleep Education I—is better at reducing daytime sleepiness for people with SDB and insufficient nightly sleep. Participants will try one of these approaches to find out how it affects their alertness during the day.
Participant Groups
2Treatment groups
Active Control
Group I: Sleep Education IActive Control1 Intervention
Participants will attend four weekly sessions to receive education about strategies to improve sleep.
Group II: PAP TreatmentActive Control1 Intervention
Participants will receive a PAP device and will attend four weekly sessions to receive education about this treatment.

PAP Treatment is already approved in European Union, United States, Canada, Japan for the following indications:

🇪🇺
Approved in European Union as CPAP Therapy for:
  • Obstructive Sleep Apnea (OSA)
  • Central Sleep Apnea (CSA)
  • Sleep-Disordered Breathing (SDB)
🇺🇸
Approved in United States as CPAP Therapy for:
  • Obstructive Sleep Apnea (OSA)
  • Central Sleep Apnea (CSA)
  • Sleep-Disordered Breathing (SDB)
🇨🇦
Approved in Canada as CPAP Therapy for:
  • Obstructive Sleep Apnea (OSA)
  • Central Sleep Apnea (CSA)
  • Sleep-Disordered Breathing (SDB)
🇯🇵
Approved in Japan as CPAP Therapy for:
  • Obstructive Sleep Apnea (OSA)
  • Central Sleep Apnea (CSA)
  • Sleep-Disordered Breathing (SDB)

Find a Clinic Near You

Who Is Running the Clinical Trial?

Wayne State University

Lead Sponsor

Trials
318
Recruited
111,000+

National Heart, Lung, and Blood Institute (NHLBI)

Collaborator

Trials
3,987
Recruited
47,860,000+

Findings from Research

A family-based asthma education program significantly improved the quality of life for both children with asthma and their parents, as shown in a study involving 34 families in each group over a 12-month period.
Children with non-allergic asthma in the experimental group demonstrated better pulmonary function, specifically in forced expiratory maneuvers, compared to the control group, highlighting the program's effectiveness in managing asthma symptoms.
Effect of Family Empowerment Education on Pulmonary Function and Quality of Life of Children With Asthma and Their Parents in Tunisia: A Randomized Controlled Trial.Dardouri, M., Sahli, J., Ajmi, T., et al.[2021]
This study aims to evaluate the effectiveness of two different continuing education (CE) activities for educators on therapeutic patient education (TPE) for COPD patients, focusing on learning outcomes, self-reported competence, educator performance, and patient outcomes.
By comparing a role-playing simulation (experimental group) to a traditional lecture (comparison group), the study seeks to determine which method better enhances educator performance in delivering TPE, ultimately aiming to improve the quality of life and reduce healthcare utilization for COPD patients.
Comparative impact of two continuing education activities targeted at COPD educators on educational outcomes: protocol for a non-randomized controlled study using mixed methods.Gagné, M., Moisan, J., Lauzier, S., et al.[2019]
A multicenter, randomized controlled trial involving 580 Chinese children aged 2-14 with moderate to severe atopic dermatitis showed that therapeutic patient education significantly reduced eczema severity and improved quality of life after 6 months.
The intervention group not only had a greater reduction in atopic dermatitis severity scores but also demonstrated improved knowledge about the use of emollients, highlighting the effectiveness of education in managing chronic skin conditions.
Therapeutic patient education in children with moderate to severe atopic dermatitis: A multicenter randomized controlled trial in China.Liang, Y., Tian, J., Shen, CP., et al.[2018]

References

Effect of Family Empowerment Education on Pulmonary Function and Quality of Life of Children With Asthma and Their Parents in Tunisia: A Randomized Controlled Trial. [2021]
Comparative impact of two continuing education activities targeted at COPD educators on educational outcomes: protocol for a non-randomized controlled study using mixed methods. [2019]
Therapeutic patient education in children with moderate to severe atopic dermatitis: A multicenter randomized controlled trial in China. [2018]
[Therapeutic education of children who are victims or at risk of a stroke]. [2017]
[Educating the asthma patient for routine illness management. Assuring long-term therapeutic success]. [2007]
Techniques and impact of education in adult asthmatics. [2016]
Outcome factors in patient education. [2019]
Applying health education theory to patient safety programs: three case studies. [2016]
Therapeutic patient education in atopic eczema. [2014]
[Therapeutic Patient Education training for nursing students: A case study.] [2019]
Current perspectives of therapeutic patient education in Italy. [2019]
[Education care in patients with psychiatric disorders in France: Psychoeducation or therapeutic patient education?] [2019]
[From Neandertal to therapeutic education]. [2016]
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top
Terms of Service·Privacy Policy·Cookies·Security